# Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension

> **NCT07212686** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Todd Sweberg** · enrollment: 30 (estimated)

## Conditions studied

- Vasodilatory Shock

## Interventions

- **DRUG:** Angiotensin-II

## Key facts

- **NCT ID:** NCT07212686
- **Lead sponsor:** Todd Sweberg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-09
- **Primary completion:** 2030-06
- **Final completion:** 2030-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07212686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07212686, "Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07212686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*